IBB iShares Biotechnology ETF

A bearish engulfing candlestick below resistance on the Biotech ETF $IBB suggesting upside exhaustion. The seasonal rally that is typical between May and September has come to an end. $AMGN $GILD $MRNA

$IBB $LLY $VKTX tax loss selling typically peaks the second week of October with a strong November December rebound for small and mid cap laggards. Not that another reason to buy at these levels is needed.

small red days on $IBB don't scare me when it's parked over its line XBI closed 151.64, still above its 200 day at 147.55. $IBB closed 209.54, still above its 50 day at 207.48 both up over 3 percent in five sessions. thursday was a breather, not a break when the index holds the line, single names get to keep swinging. my watchlist stays heavy imo

close was not ugly ngl $IBB closed 209.54, down 0.95 percent off a 211.55 close, and XBI closed 151.64, down 0.75 percent both are still up more than 3 percent in five sessions IBB is still over its 50 day near 207.48, and that XBI level is still over its 200 day at 147.55 that reads like a breather after a run to me, not a regime flip. large caps held it together, small caps stay picky into Friday imo

Large caps holding the sector up today imo. $IBB up 0.9 percent at 212.48 and over its 50 day, $XBI flat at 153.36 after tagging 155.78, still over its 200 day

🟢 $IBB 220C Nov 20 💰 $227,800 premium 💵 $0/contract 📊 6.5x Vol/OI 📍 Spot $210.02 💰 Large premium 🌊 Dark Flow | Options Flow

$IBB options flow lesson: chart and flow can disagree. Options activity describes the derivatives tape while the daily chart describes price structure. A disagreement is information, not an error to hide. The alert snapshot shows $417K in the Jun 17 $200 puts. Volume was 299.0x standing open interest at capture. Intraday volume does not establish whether a position was opened or held; the next settled open interest is the check.

Biotech and healthcare innovation is having a tough week. Breaking notable nearby support in many of these companies. $IBB $XBI $ARKG

$IBB - Per : "We need a quick recovery back above the yellow & blue line in order for the bull-bio market to stay on course"

$IBB Here's the story: **Darya Shipilova**, 28, a lab worker at the Irkutsk Anti-Plague Research Institute in Siberia, died Oct 2 of severe pneumonia. Colleagues say she broke a test tube with live plague on Sept 25 — but Russia denies it, told WHO there are no plague cases, and calls the cause "pneumonia of unknown origin." Nearly 200 contacts are under medical observation, all reportedly testing negative so far. The incident blew up internationally: Trump said he'll call Putin about it "very soon," Rubio wants more transparency, and the State Department reportedly sent Moscow a formal complaint about withholding information. WHO says the risk to the general public looks low.

$IBB president Trump to talk to Putin about the plague death in Siberia. This is very serious bacteria. All the genetics and vaccines stocks will recover tomorrow.

Notable angst in this range on display for biotech $IBB and $XBI. Bearish engulfing bar and tracking heavier volume. Still contained for now, but follow-through selling below 200 would make this more than just a one-off bad day for the sector.